Two Sigma Advisers
CRBU icon

Two Sigma Advisers’s Caribou Biosciences CRBU Stock Holding History

Two Sigma Advisers’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,115,700
Closed -$1.77M – 499
2025
Q4 		$1.77M Sell
1,115,700
-111,700
-9% -$234K ﹤0.01% 1232
2025
Q3 		$2.86M Sell
1,227,400
-220,400
-15% -$416K 0.01% 968
2025
Q2 		$1.82M Sell
1,447,800
-59,400
-4% -$58.4K ﹤0.01% 1165
2025
Q1 		$1.38M Buy
1,507,200
+36,500
+2% +$47.4K ﹤0.01% 1316
2024
Q4 		$2.34M Buy
1,470,700
+416,600
+40% +$838K 0.01% 1045
2024
Q3 		$2.07M Buy
1,054,100
+18,400
+2% +$37.7K ﹤0.01% 1040
2024
Q2 		$1.7M Buy
1,035,700
+989,300
+2,132% +$3.16M ﹤0.01% 1278
2024
Q1 		$238K Sell
46,400
-22,400
-33% -$138K ﹤0.01% 2154
2023
Q4 		$394K Buy
68,800
+54,800
+391% +$271K ﹤0.01% 2009
2023
Q3 		$66.9K Buy
+14,000
New +$86.9K ﹤0.01% 2253

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Two Sigma Advisers's CRBU Position: Q1 2026 in Review

Two Sigma Advisers sold out of Caribou Biosciences (CRBU) in Q1 2026, closing a stake of 1,115,700 shares — an estimated $1.77M sold.

Two Sigma Advisers first reported a position in CRBU in Q3 2023 and held it in 10 quarters. The position peaked at $2.86M in Q3 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Two Sigma Advisers reported no remaining Caribou Biosciences position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 1,115,700 Caribou Biosciences shares in Q1 2026, an estimated $1.77M.
  • Two Sigma Advisers first reported a position in Caribou Biosciences in Q3 2023 and held it in 10 quarters.
  • Two Sigma Advisers's Caribou Biosciences position peaked at $2.86M in Q3 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.